Atlas Trials

Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Clinical trial NCT06364124 · UNKNOWN

Trial details

NCT number
NCT06364124
Sponsor
Beijing Luhe Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
STEMI
Start date
2023-06-01
Primary completion
2024-06-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.